Belpointe Asset Management’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,300	Closed	-$40K	–	622
2023 Q1	$40K	Buy	5,300 +1,896	+56%	+$14.3K	﹤0.01%	1848
2022 Q4	$34.5K	Buy	+3,404	New	+$34.5K	﹤0.01%	1832